Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society.
Giancarlo Marra,Maria P Laguna,Jochen Walz,Christian P Pavlovich,Fernando Bianco,Justin Gregg,Amir H Lebastchi,Herbert Lepor,Petr Macek,Soroush Rais-Bahrami,Cary Robertson,Daniel Rukstalis,Georg Salomon,Osamu Ukimura,Andre L Abreu,Yann Barbe,Xavier Cathelineau,Giorgio Gandaglia,Arvin K George,Juan Gomez Rivas,Rajan T Gupta,Nathan Lawrentschuk,Veeru Kasivisvanathan,Derek Lomas,Bernard Malavaud,Daniel Margolis,Yoh Matsuoka,Sherif Mehralivand,Marco Moschini,Marco Oderda,Hazem Orabi,Ardeshir R Rastinehad, Mesut Remzi,Ariel Schulman,Toshitaka Shin,Takumi Shiraishi,Abhinav Sidana,Sunao Shoji,Armando Stabile,Massimo Valerio, Varaha S Tammisetti,Wei Phin Tan,Willemien VAN DEN Bos,Arnaud Villers,Peter-Paul Willemse,Jean DE LA Rosette,Thomas Polascik,Rafael Sanchez-Salas Minerva urology and nephrology（2022）
摘要
The present study detailed an initial consensus on the use of MB in FT for PCa. This is until evidence becomes available on the subject.
更多查看译文
关键词
Prostatic neoplasms cancer,Biomarkers,tumor,Delphi technique
AI 理解论文
溯源树
样例
